Seton Hall University, Rider University and Princeton University top the list of highest grossing women's college swimming and diving programs in New Jersey in 2016
Somos, Inc., a leading registry management and data solutions company, is pleased to announce the appointment of telecommunications executive Carol Wirsbinski to its Board of Directors.
Merck (NYSE:MRK), known as MSD outside the United States and Canada, will hold its second-quarter 2019 sales and earnings conference call with institutional investors and analysts at 8:00 a.m.
By the Numbers: Rutgers, The State University of New Jersey ranks 20th best in the nation for its graduate fine arts program, study finds
Rutgers, The State University of New Jersey finished in a tie for 20th in a peer-assessment ranking of the best fine arts schools by U.S. News that examined 229 campuses around the nation in areas such as graphic design and painting.
Twenty-nine states, including New Jersey, maintain personal income tax exemptions, even though the 2017 Tax Cuts and Jobs Act suspended such exemptions at the federal level, according to a Tax Foundation analysis.
Seton Hall University, Rider University and Princeton University top the list of highest grossing women's college swimming and diving programs in the state in 2016
Holiday City-Berkeley was ranked the poorest town in New Jersey in a 24/7 Wall St. analysis examining small communities with high poverty rates and financial hardships.
New Jersey finished third in a Tax Foundation analysis of state and local tax collections per capita – ranked from highest to lowest.
KONICA MINOLTA BUSINESS SOLUTIONS U.S.A., INC: Konica Minolta Ranked Among World’s Most Elite 501 Managed Service Providers
Konica Minolta Business Solutions U.S.A., Inc. (Konica Minolta) announced today that the company’s IT Services Division, All Covered (All Covered), has been named as one of the world’s premier managed service providers on the prestigious 12th-annual Channel Futures MSP 501 rankings.
MERCK: Merck Highlights Commitment to HIV Research with Presentations for Investigational Anti-HIV Agent MK-8591 at IAS 2019
Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that the results from studies evaluating MK-8591, an investigational nucleoside reverse transcriptase translocation inhibitor (NRTTI), are scheduled to be presented at the 10th International AIDS Society Conference on HIV Science (IAS 2019) taking place July 21 – 24, 2019 in Mexico City.